Electroconvulsive therapy in the medically ill

Psychiatric Clinics of North America

Volumn 25, Issue 1, 2002, Pages 177-193

  Rasmussen, Keith G ^a,b   Rummans, Teresa A ^a   Richardson, Jarrett W ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; DANTROLENE; DOPAMINE RECEPTOR STIMULATING AGENT; LORAZEPAM; MUSCLE RELAXANT AGENT; NEUROLEPTIC AGENT;

ANTICOAGULATION; ARTIFICIAL HEART PACEMAKER; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; COMORBIDITY; CONGENITAL BLOOD VESSEL MALFORMATION; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DEFIBRILLATOR; DEMENTIA; ELECTROCONVULSIVE THERAPY; EPILEPSY; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; INTRACRANIAL TUMOR; LUNG DISEASE; MENTAL DISEASE; MOTOR DYSFUNCTION; NEUROLEPTIC MALIGNANT SYNDROME; NEUROLOGIC DISEASE; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; TREATMENT CONTRAINDICATION; VALVULAR HEART DISEASE;

EID: 0036203593     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0193-953X(03)00057-1     Document Type: Review

References (103)

1. Maintenance electroconvulsive therapy for Parkinson's disease
2. Electroconvulsive therapy in the high-risk patient
3. Cardiac rupture during electroconvulsive therapy
4. Diagnosis and management of ischemic heart disease in the patient scheduled to undergo electroconvulsive therapy
5. Electroconvulsive therapy and intracranial aneurysm
6. Electrical convulsion therapy in the treatment of epilepsy
7. Comparative effects of esmolol and labetolol to attenuate hyperdynamic states after electroconvulsive therapy
8. Electroconvulsive therapy for post-stroke depressed geriatric patients
9. Recurrent post-ECT dyskinesias
10. ECT in post-stroke major depression
11. ECT in a patient with aortic aneurysm
12. Status epilepticus following ECT in a patient taking theophylline
13. Anesthetic considerations of cardiovascular risk during electroconvulsive therapy
14. ECT and Parkinson's disease revisited: A "naturalistic" study
15. Arterial hypertension and multiple cerebral aneurysms in a patient treated with electroconvulsive therapy
16. ECT in patients with intracranial aneurysm
17. Using electroconvulsive therapy for patients with neurological disease
18. ECT in Parkinson's disease: Changes in motor symptoms, monoamine metabolites and neuropeptides
19. Maintenance ECT in Parkinson's disease
20. ECT after cerebral aneurysm repair
21. ECT and delirium in Parkinson's disease
22. ECT for organic catatonia due to hereditary cerebellar ataxia
23. Effects of electroconvulsive therapy on cardiac function in patients without heart disease
24. Safe use of ECT with an intracranial aneurysm
25. ECT in psychogeriatric practice: A study of risk factors, indications and outcome
26. The identification and management of patients with a high risk for cardiac arrhythmias during modified ECT
27. Electroconvulsive therapy for treatment of intractable seizures: Initial findings in two children
28. Generalized nonconvulsive status epilepticus after electroconvulsive therapy
29. An unusual effect of ECT on drug-induced parkinsonism and tardive dystonia
30. Subclinical status epilepticus following ECT
31. Early electroconvulsive treatment of a patient who had artificial aortic and mitral valves
32. Status epilepticus: Frequency, etiology, and neurological sequelae
33. Maintenance ECT for treatment of therapyresistant paranoid schizophrenia and Parkinson's disease
34. Effects of electroconvulsive therapy on mood, parkinsonism, and tardive dyskinesia in a depressed patient: ECT and dopamine systems
35. ECT and neurological disorders
36. ECT in the presence of a cerebral aneurysm
37. Electroconvulsive therapy and intracranial aneurysm: Prevention of blood pressure elevation in a normotensive patient by hydralazine and propranolol
38. Remission of tardive dystonia with ECT
39. Safe administration of ECT in a patient with a calcified frontal mass
40. Dexamethasone pretreatment for ECT in a patient with meningioma
41. Use of esmolol to control bleeding and heart rate during electroconvulsive therapy in a patient with an intracranial aneurysm
42. Atropine and glycopyrrolate as ECT preanesthesia
43. Tardive dystonia, catatonia, and electroconvulsive therapy
44. Electroconvulsive therapy in two former neurosurgical patients: Skull prosthesis and ventricular shunt
45. Electroconvulsive therapy in the presence of brain tumor: Case reports and an evaluation of risk
46. ECT-induced interictal delirium in patients with a history of CVA
47. Multiple sclerosis and ECT: Possible value of gadolinium-enhanced magnetic resonance scans for identifying high-risk patients
48. Prospective uses of ECT in the presence of intracranial tumors
49. Electroconvulsive therapy in a patient with a cerebellar meningioma
50. Use of electroconvulsive therapy during pregnancy
51. ECT and Parkinson's disease
52. Electroconvulsive therapy for poststroke depression
53. ECT in the presence of intracranial aneurysm
54. ECT treatment of demented elderly patients with major depression: A retrospective study of efficacy and safety
55. Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: A report of 5 cases
56. ECT in the presence of brain tumor and increased intracranial pressure: Evaluation and reduction of risk
57. Status epilepticus as a complication of concurrent electroconvulsive and theophylline therapy
58. Atrial fibrillation, anticoagulation, and electroconvulsive therapy
59. Malignant catatonia
60. Implantable cardioverter-defibrillators: Implications for the nonelectrophysiologist
61. Electroconvulsive therapy in tardive dystonia
62. ECT in Parkinson's disease: Neuropsychological response
63. Electroconvulsive therapy in Parkinson's disease: 30 Month follow up
64. Electroconvulsive therapy for the physical signs of Parkinson's disease without depressive disorder
65. Nonconvulsive status epilepticus after the ninth electroconvulsive therapy
66. The benefits and risks of ECT for patients with primary dementia who also suffer from depression
67. Electroconvulsive therapy in patients with aortic stenosis
68. Treatment of Parkinson's disease with electroconvulsive therapy
69. Electroconvulsive therapy in patients taking theophylline
70. ECT in patients with cerebral palsy
71. Electroconvulsive therapy in patients with heart failure or valvular heart disease
72. Electroconvulsive therapy for epilepsy and major depression
73. Open-trial response to antidepressant treatment in elderly patients with mixed depression and cognitive impairment
74. Cardiovascular morbidity in high-risk patients during ECT
75. Cortical blindness after electroconvulsive therapy
76. ECT post eye surgery: Two cases and a review of the literature
77. Anticonvulsant and antidepressant properties of electroconvulsive therapy: A proposed mechanism of action
78. ECT and intracranial vascular masses
79. Electroshock therapy and multiple sclerosis
80. Electroshock in the presence of organic disease of the central nervous system
81. Electroconvulsive therapy in the treatment of episodic aggressive dyscontrol in psychotic patients
82. Maintenance ECT as adjunctive treatment to dopaminergic drugs in Parkinson's disease
83. Electroconvulsive therapy in patients with structural diseases of the central nervous system
84. ECT in a patient with a frontal craniotomy and residual meningioma
85. ECT in patients with major depressive disorder and low cardiac output
86. Improvement in depression-related cognitive dysfunction following ECT
87. Blood pressure reduction with ECT response
88. Use of transesophageal atrial pacing during electroconvulsive therapy
89. Electroshock therapy in the asthmatic patient
90. Control of grand mal epilepsy with electro-shock
91. Low-dose esmolol bolus reduces seizure duration during electroconvulsive therapy: A double-blind, placebo-controlled study
92. Intracranial haemodynamics during attenuated responses to electroconvulsvie therapy in the presence of an intracerebral aneurysm
93. ECT and grand mai epilepsy
94. Electroconvulsive therapy during high-risk pregnancy
95. Electroconvulsive therapy in the acute poststroke period
96. Intracerebral hemorrhage following electroconvulsive therapy
97. Maintenance electroconvulsive therapy for intractable Parkinson's disease
98. Electro-convulsive treatment: A help for epileptics
99. The effect of electroconvulsive therapy on tardive dyskinesia: A prospective study
100. ECT for refractory Parkinson's disease
101. Cardiovascular complications of ECT in depressed patients with cardiac disease
102. ECT in the treatment of patients with neurological and somatic disease